Apple's Slowing Growth Shows It's Not Immune To Risks

A drumbeat of bad news for Apple is casting doubt on the argument that the world’s most valuable company is immune to risks related to economic turbulence, as reported by Bloomberg News.

Apple's lack of growth and the high cost of its stock create a disconnect that's hard to ignore. I Photo: Justin Brown Flickr

Tepid sales in China for its new iPhone models have fueled concerns about Apple’s ability to justify its lofty valuation.

This comes as the company grapples with political tensions with China and issues related to overheating devices. KeyBanc this month became the latest firm to downgrade the stock.

Apple's lack of growth and the high cost of its stock create a disconnect that's hard to ignore, according to James Abate, the chief investment officer at Centre Asset Management.

WEEKLY FEATURE : Jose Mari Chan And The Christmas Anthem